HumanCo Acquisition $287.5 million IPO

Davis Polk advised the underwriter in connection with the initial public offering of 28,750,000 units of HumanCo Acquisition Corp., including 3,750,000 units purchased pursuant to the full exercise of the underwriter’s option to purchase additional units, for aggregate proceeds of $287.5 million. Each unit consists of one share of Class A common stock and one-half of one warrant to purchase one share of Class A common stock of HumanCo Acquisition Corp. The Class A common stock and warrants are expected to be listed on the Nasdaq Capital Market under the symbols “HMCO” and “HMCOW”, respectively.

HumanCo Acquisition Corp. is a special purpose acquisition company (SPAC) whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. Although HumanCo Acquisition Corp. is not limited to a particular industry or geographic region for purposes of consummating a business combination, the company intends to focus on health and wellness and related industries in the United States.

The Davis Polk corporate team included partners Derek Dostal and Deanna L. Kirkpatrick, counsel Joseph S. Payne and associate David Giron. The tax team included counsel Kiara L. Rankin and associate Dov Sussman. Counsel Marcie A. Goldstein provided FINRA advice. All members of the Davis Polk team are based in the New York office.